An observational study on roxadustat in the treatment of renal anemia in peritoneal dialysis patients
Latest Information Update: 16 Feb 2022
At a glance
- Drugs Roxadustat (Primary) ; Recombinant erythropoietin; Recombinant erythropoietin
- Indications Anaemia
- Focus Therapeutic Use
- 01 Feb 2022 Results published in the Journal of the Formosan Medical Association
- 01 Feb 2022 Status changed from recruiting to completed, as per results published in the Journal of the Formosan Medical Association.
- 03 Dec 2020 New trial record